Method for preparing morphinan derivative having diaryl ether skeleton using novel copper catalyst
AssigneeNippon Chemiphar Co., Ltd.
InventorMasaaki Hirose
Life of this patent
Estimating the term…
Abstract
Provided is a method which is for preparing a morphinan derivative having a diaryl ether skeleton represented by general formula (III) (In the formula, R1 represents a hydrogen atom, etc., R2, R3, and R4 are the same or different and each represent a hydrogen atom, or an arbitrary substituent, etc., R5 represent a hydrogen atom, a hydroxy group, etc., R14 and R15 are the same or different and each represent a hydrogen atom, or an arbitrary substituent, etc.), and in which a phenyl group is introduced into the 4-position phenol of a morphinan derivative through the Ullmann reaction of a system using a monovalent copper compound or a novel catalytic system simultaneously using a monovalent copper compound and zero-valent metallic copper.
Claims22
A method for preparing a morphinan derivative, the method comprising:
- reacting a compound represented by the following general formula (I):
- wherein R1 represents a hydrogen atom, a C1-10 alkyl group optionally having a substituent, a C3-6 cycloalkyl C1-6 alkyl group optionally having a substituent, an aralkyl group optionally having a substituent, a heteroarylalkyl group optionally having a substituent, a C3-6 cycloalkyl group optionally having a substituent, a C6-10 aryl group optionally having a substituent, a heteroaryl group optionally having a substituent, a C2-6 alkenyl group optionally having a substituent, or an amino protecting group,
- R2, R3, and R4 are the same or different and each represent a hydrogen atom or an substituent, or
- with respect to the moiety:
- of the general formula (I),
- R2 and R4 are bonded to each other to represent:
- wherein a double line consisting of a solid line and a broken line represents a single bond or a double bond,
- wherein, when the double line consisting of a solid line and a broken line between A and B is a single bond, then A and B are the same or different and each represent CR6R7, C═O, or NR8, wherein R6 and R7 are the same or different and each represent a hydrogen atom, —C(═O)—R9, or —CR10(OH)—R11, and R8 to R11 each represent a hydrogen atom or an arbitrary substituent, and
- when the double line consisting of a solid line and a broken line between A and B is a double bond, then A and B are the same or different and each represent CR6 or N, wherein R6 and R9 to R11 each represent the same as mentioned above, and
- when the double line consisting of a solid line and a broken line between D and D is a single bond, then D represents CH2, and when the double line consisting of a solid line and a broken line between D and D is a double bond, then D represents CH, or
- R2 to R4 are bonded to each other to represent:
- wherein X represents CH2, NR8 (R8 represents a hydrogen atom or an arbitrary substituent), or O, Y represents CH2 or C═O, and R12 represents an amino protecting group or an acyl group, and
- R5 represents a hydrogen atom, a hydroxy group, or —OR13 (R13 represents a hydroxy protecting group),
- with a compound represented by the following general formula (II):
- wherein R14 and R15 are the same or different and each represent a hydrogen atom or an arbitrary substituent, and Hal represents a halogen atom,
- in an organic solvent in the presence of a base, a monovalent copper compound, and a zero-valent metallic copper, wherein the monovalent copper compound is at least one selected from the group consisting of cuprous chloride, cuprous bromide, cuprous iodide and cuprous oxide, and the zero-valent metallic copper is copper powder, and
- the morphinan derivative being represented by the following general formula (III):
- wherein R1 to R5, R14, R15, and D each represent the same as mentioned above.
Dependencies are inferred from the claim text.